( SLR) posted a first-quarter loss, lowered its second-quarter forecast and outlined a $1.5 billion financing package to meet near-term debt obligations. The Milpitas, Calif.-based electronic-parts seller lost $52.5 million, or 8 cents a share, before $72.9 million of restructuring charges in the quarter ending Nov. 30. Excluding the amortization of goodwill and other charges, Solectron broke even. The company expects second-quarter earnings of between break-even and 3 cents a share. Analysts had been expecting earnings of 4 cents to 10 cents a share. Solectron also said it will sell $1 billion in adjustable conversion-rate equity security units, or ACES, and received a pledge for $500 million of revolving credit facilities.
Earnings Reports & Outlooks
Investors continued to look past
revenue restatement to bid up the video-game maker on the strength of a revised earnings outlook. The company said after the bell Monday that it would adjust its results for 2000 and the first nine months of 2001 downward to fix its accounting for returned merchandise. It also expects results for its most recent quarter to come in below expectations, although earnings for the first quarter of 2002 will be far greater than expected. Take-Two was up about 8% in the premarket session to $14.66.
( DCTM)said revenue in 2002 will be higher than previously estimated, and the company expects to be profitable in the year. The business-software maker said it expects revenue of $212 million to $218 million in fiscal 2002 and earnings of 4 cents to 6 cents a share; analysts were expecting the company to lose 3 cents a share. The estimate includes Documentum's recent acquisition of Bulldog Group. The company didn't comment on expectations for its current quarter, but said for the first quarter of 2002, it expects revenue of $46 million to $48 million and a loss of 10 cents to 13 cents a share.
posted a slightly narrower-than-expected second-quarter loss and said it will tap the convertibles market. The laser-device maker said it lost $1.5 million, or 5 cents a share, on revenue of $40 million in the second quarter; analysts were expecting a loss of 6 cents a share in the period. The company said its near-term outlook remains uncertain. Electro-Scientific also said it plans to sell $125 million of convertible subordinated notes due 2006 in a private placement.
Mergers, Acquisitions & Joint Ventures
agreed to buy the U.S.-based memory unit of
, Japan's biggest chipmaker, which said it is exiting the low-margin DRAM business. Micron plans to complete the purchase of Toshiba's Dominion Semiconductor LLC in January of 2002, and the two companies plan to discuss cooperation on higher-value-added DRAM products in the future.
plans to raise $150 million through a private offering of convertible subordinated notes. The notes will have a seven-year term, and the company may issue up to an additional $22.5 million of notes to cover overallotments. The telecommunications company said it will use the proceeds for general corporate purposes, including possible future acquisitions.
shares continued to rise Tuesday, a day after the company released data showing its anticancer drug INGN-201 was safe in a study. Introgen released studies Tuesday showing the treatment complemented the effects of a breast-cancer treatment in a preclinical study and enhanced the immune response of mice against tumors.
raised its quarterly earnings guidance and said it received FDA clearance to sell a generic anticholesterol drug. The Pittsburgh-based pharmaceuticals company said it expects to earn 54 cents to 56 cents a share in the fiscal third quarter, above analysts' estimate of 40 cents a share. Mylan received clearance to sell a generic version of
entered an online advertising deal with
AOL Time Warner's
America Online. The Norwalk, Conn.,-based ticket discounter said its travel products will be available across several AOL products, including Netscape and Mapquest, in its first major thrust into online marketing. Terms of the agreement weren't disclosed.
delivered the first prototype of its Genexpert DNA detection system to the U.S. Army Medical Research Institute. The system is the first PCR-based instrument that can fully automate all of the steps necessary for DNA detection, and will allow operators with minimal training to obtain a sample in less than 30 minutes. The medical device maker said it expects the system to be commercially available in 2003..